Skip to main content
Amyris aims to become leading synthetic biology firm
1/6/2020

Synthetic biology firm Amyris announced that it has delivered its first shipment of fermentation-made cannabinoid molecules to LAVVAN that will be utilized in industries that manufacture personal care and beauty products. LAVVAN's clients include companies in the food, beverage and pharmaceutical industries, and their strategic partnership with Amyris is expected to build the latter's position as a leading synthetic biology company.

Full Story: